A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1195, in 18- to 55-Year-Old Healthy Participants
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Loading…
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Loading…